About 500 reports

  • B) US cardiovascular disease market size
  • A) Global cardiovascular disease market split
  • Cardiovascular Disease
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • CARDIOVASCULAR DISEASE THERAPEUTICS MARKET, GLOBAL, PIPELINE FOR CARDIOVASCULAR DISEASES BY
  • A) Global cardiovascular disease market split
  • Cardiovascular Disease
  • World
  • Market Size
  • Novartis AG
  • Sanofi S.A.
  • 5.3.1 Cardiovascular Disease
  • Cardiovascular Disease Therapeutics Market, Global,
  • Cardiovascular Disease
  • World
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.

Depending on original data sources used, the definition of cardiovascular disease (CVD) diagnostics is established.

  • Cardiovascular Disease
  • Chronic Disease
  • Demand

Depending on original data sources used, the definition of cardiovascular disease (CVD) treatments is established.

  • Cardiovascular Disease
  • Chronic Disease
  • Pathology
  • Demand
  • GLOBAL CARDIOVASCULAR DISEASES DEATHS BY TYPE,
  • SNAPSHOT OF CARDIOVASCULAR DISEASE IN EUROPE,
  • Cardiovascular Disease
  • Abbott Laboratories, Inc.
  • Biotronik SE & Co.
  • Boston Scientific Corporation
  • LivaNova PLC
  • Global Cardiovascular Drugs Market, Historic and Forecast, Split By Segment, 2013 - 2021
  • PERSONALIZED MEDICINE FOR TREATMENT OF CARDIOVASCULAR DISORDERS

The prevalence of cardiovascular diseases is high in this region.

  • Cardiovascular Disease
  • World
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • SNAPSHOT OF CARDIOVASCULAR DISEASE IN EUROPE, 2017
  • INCIDENCE OF CARDIOVASCULAR DISEASE IN ITALY, BY
  • Cardiovascular Disease
  • World
  • Boston Scientific Corporation
  • Cardiac Science Corporation
  • LivaNova PLC
  • GLOBAL DEATHS FROM CARDIOVASCULAR DISEASES, 2015
  • U.S.: PERCENTAGE OF CAUSES OF HEART FAILURE RELATED
  • Cardiovascular Disease
  • World
  • Market Size
  • Collagen Solutions plc
  • Jellagen Pty Ltd
  • INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES (CVDS)
  • Cardiovascular Disease
  • World
  • GE Healthcare Limited
  • Mortara Instrument, Inc.
  • Spacelabs Healthcare, Inc.
  • PUBLIC AWARENESS ABOUT CARDIOVASCULAR DISEASES (CVDS)
  • Cardiac Management
  • Cardiovascular Disease
  • World
  • Forecast
  • Medtronic, Inc.
  • INCREASING AWARENESS ABOUT CARDIOVASCULAR DISEASES (CVDS)
  • GROWTH OF AGING POPULATION
  • Cardiovascular Disease
  • Medical Equipment
  • World
  • Forecast
  • Medtronic, Inc.
  • CARDIOVASCULAR DISEASE SEGMENT TO ACCOUNT FOR THE LARGEST
  • CARDIOVASCULAR DISEASE APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • Cardiovascular Disease
  • Market Size
  • Compumedics Limited
  • Deltex Medical Group plc
  • Getinge Group
  • RISING INCIDENCE OF CARDIOVASCULAR DISEASES (CVDS)
  • SUPPORTIVE GOVERNMENT AND NON-GOVERNMENT INITIATIVES
  • Cardiovascular Disease
  • Forecast
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Market drivers
  • Geographical segmentation

PART ##: Market drivers DEMAND FOR CARDIOVASCULAR DISEASE DIAGNOSTICS The prevalence of cardiovascular diseases is on the rise with each year.

  • Cardiovascular Disease
  • World
  • Cardinal Health, Inc.
  • CONMED Corporation
  • Medtronic, Inc.
  • INCIDENCE OF CARDIOVASCULAR DISEASE IN ITALY, BY SEX, 2000-2015
  • INCIDENCE OF CARDIOVASCULAR DISEASE IN FRANCE, BY SEX, 2000-2015
  • Cardiovascular Disease
  • World
  • Biotronik SE & Co.
  • Boston Scientific Corporation
  • Cochlear Limited
  • Incidences of Cardiovascular Diseases
  • PERCENTAGE OF POPULATION SUFFERING FROM CARDIOVASCULAR DISEASE IN USA (2009-2012)
  • Cardiovascular Disease
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • Global heart failure drugs market is expected to grow to $6,804.24 mn by 2022

CO M PART ##: Appendix LIST OF ABBREVIATIONS ACE APAC ARB CAD CDC CFO angiotensin-converting enzyme Asia-Pacific angiotensin II receptor blocker coronary artery disease Centers for Disease Control and Prevention complete response letter cardiovascular disease chief financial officer CRL CVD

  • Beta-Blocker
  • Cardiovascular Disease
  • Amgen Inc.
  • AstraZeneca PLC
  • Novartis AG
  • High cost of cardiovascular diseases (CVD) procedures
  • Market definition
  • Cardiovascular Disease
  • Hospital
  • United Kingdom
  • World
  • Forecast
  • HIGHLIGHTS
  • INCREASE IN INCIDENCE OF CARDIAC DISORDERS AND RISE IN OLDER POPULATION
  • Blood Device
  • Cardiovascular Disease
  • World
  • Omron Corporation
  • Welch Allyn Inc.
  • CARDIAC PACEMAKERS MARKET IN AMERICAS
  • OVERVIEW

In the UK, hospital admission for cardiovascular diseases increased due to increased cardiovascular disease prescriptions and operations over the last few decades making it second leading cause of death in the year 2014.

  • Cardiovascular Disease
  • United States
  • Forecast
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Diabetes complications
  • MAJOR COMPLICATIONS OF DIABETES

The treatment of cardiovascular diseases cost a huge amount to the nation.

  • Cardiovascular Disease
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Diabetes complications
  • OTHER PROMINENT VENDORS

Diabetes acts as one of the major factors leading to cardiovascular diseases.

  • Beta-Blocker
  • Cardiovascular Disease
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG
  • Public awareness of cardiovascular diseases
  • Stringent regulatory framework
  • Cardiovascular Disease
  • Hospital
  • World
  • Forecast
  • Medtronic, Inc.
  • By Patient Type
  • By Patient Type

IN ARGENTINA, CARDIOVASCULAR DISEASES CONTRIBUTE TO ##% MORTALITY.

  • Cardiovascular Disease
  • World
  • Market Size
  • Abbott Laboratories, Inc.
  • Abiomed, Inc.
  • Demand (Billion Yuan)
  • North (Billion Yuan)
  • Cardiovascular Disease
  • China
  • Supply
  • Bristol-Myers Squibb Company
  • Tasly Pharmaceutical Co., Ltd.
  • Economic burden of cardiovascular diseases in top five European countries
  • Cardiac rhythm management devices market in EMEA
  • Cardiovascular Disease
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Sorin S.p.A.
  • Radiofrequency ablation market in EMEA 2016-2021 ($ millions)
  • RADIOFREQUENCY ABLATION MARKET IN EMEA

In 2014, Europe recorded four million deaths related to cardiovascular diseases.

  • Cardiovascular Disease
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Stryker Corporation
  • 3.3 FACTORS INFLUENCING MARKET
  • Application

In cardiovascular diseases ablation finds its application mainly in atrial fibrillation and tachycardia.

  • Cardiovascular Disease
  • World
  • Market Size
  • Boston Scientific Corporation
  • CONMED Corporation
  • BYAPPLICATION
  • 10 REGIONAL ANALYSIS

IN ARGENTINA, CARDIOVASCULAR DISEASES CONTRIBUTE TO ##% MORTALITY.

  • Cardiovascular Disease
  • World
  • Market Size
  • Abiomed, Inc.
  • Medtronic, Inc.